Skip to main content

CORRECTION article

Front. Endocrinol., 20 September 2021
Sec. Clinical Diabetes
Volume 12 - 2021 | https://doi.org/10.3389/fendo.2021.771445
This article is part of the Research Topic Covid-19 and Diabetes, volume II View all 31 articles

Corrigendum: ACE Gene Variants Rise the Risk of Severe COVID-19 in Patients With Hypertension, Dyslipidemia or Diabetes: A Spanish Pilot Study

This article is a correction to:

  1. ACE Gene Variants Rise the Risk of Severe COVID-19 in Patients With Hypertension, Dyslipidemia or Diabetes: A Spanish Pilot Study

    1. Read original article
María ÍiguezMaría Íñiguez1Patricia Prez-MatutePatricia Pérez-Matute1Pablo Villoslada-BlancoPablo Villoslada-Blanco1Emma Recio-FernandezEmma Recio-Fernandez1Diana Ezquerro-PrezDiana Ezquerro-Pérez2Jorge AlbaJorge Alba2M. Lourdes Ferreira-LasoM. Lourdes Ferreira-Laso3Jos A. Oteo,*José A. Oteo1,2*
  • 1Infectious Diseases, Microbiota and Metabolism Unit, Infectious Diseases Department, Center for Biomedical Research of La Rioja (CIBIR), Logroño, Spain
  • 2Infectious Diseases Department, Hospital Universitario San Pedro, Logroño, Spain
  • 3Department of Anesthesiology and Postoperative Care, Hospital Universitario San Pedro, Logroño, Spain

A Corrigendum on
ACE Gene Variants Rise the Risk of Severe COVID-19 in Patients With Hypertension, Dyslipidemia or Diabetes: A Spanish Pilot Study

By Íñiguez M, Pérez-Matute P, Villoslada-Blanco P, Recio-Fernandez E, Ezquerro-Pérez D, Alba J, Ferreira-Laso ML and Oteo JA (2021). Front. Endocrinol. 12:688071. doi: 10.3389/fendo.2021.688071.

Error in Figure/Table

In the original article, there was a mistake in Table 2 as published. Alleles of rs4343 polymorphism were incorrectly written. The corrected Table 2 appears below.

TABLE 2
www.frontiersin.org

Table 2 Genotype frequencies of rs4341 and rs4343 polymorphisms in COVID-19 patients according to its hypertensive, dyslipidemic or diabetic status.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: COVID-19, angiotensin converting enzyme, polymorphisms, hypertension, dyslipidemia, diabetes

Citation: Íñiguez M, Pérez-Matute P, Villoslada-Blanco P, Recio-Fernandez E, Ezquerro-Pérez D, Alba J, Ferreira-Laso ML and Oteo JA (2021) Corrigendum: ACE Gene Variants Rise the Risk of Severe COVID-19 in Patients With Hypertension, Dyslipidemia or Diabetes: A Spanish Pilot Study. Front. Endocrinol. 12:771445. doi: 10.3389/fendo.2021.771445

Received: 06 September 2021; Accepted: 08 September 2021;
Published: 20 September 2021.

Edited and reviewed by:

Hamad Ali, Kuwait University, Kuwait

Copyright © 2021 Íñiguez, Pérez-Matute, Villoslada-Blanco, Recio-Fernandez, Ezquerro-Pérez, Alba, Ferreira-Laso and Oteo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: José A. Oteo, jaoteo@riojasalud.es

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.